July 29 (Reuters) - Memscap SA MEMS.PA :
* H1 OPERATING LOSS -100,000 EUR VERSUS 100,000 EUR PROFIT
YEAR
AGO
* H1 REVENUE 6.1 MILLION EUR
* HALF-YEAR EBITDA AT 0.5 MILLION EUROS AND Q2 EBITDA AT 0.2
MILLION EUROS DESPITE AN UNPRECEDENTED MACROECONOMIC ENVIRONMENT
* IMPACT OF COVID-19 PANDEMIC ON GROUP'S AVIONICS BUSINESS
FULLY
OFFSET BY SIGNIFICANT GROWTH OF MEDICAL BUSINESS
* INCREASE OF AVAILABLE LIQUIDITIES UP TO 4.2 MILLION EUROS
AT 30
JUNE 2020
* OPTICAL COMMUNICATIONS BUSINESS IMPACTED BY COVID-19
PANDEMIC
AND RELATED CLOSURE OF US PRODUCTION SITE FOR MORE THAN TWO
WEEKS
* POTENTIAL IMPACT OF PANDEMIC REMAINS VERY UNCERTAIN BASED
ON
CURRENT AVAILABLE INFORMATION
* PRODUCTION AT GROUP'S NORWEGIAN SITE (STANDARD PRODUCTS
DIVISION) HAS FACED NO SIGNIFICANT IMPACT RESULTING FROM
COVID-19 PANDEMIC AT JUNE 30, 2020
* PURSUES ITS STRATEGY FOCUSED ON AVIONICS, MEDICAL AND
OPTICAL
COMMUNICATIONS SEGMENTS AS WELL AS INCREASING FLEXIBILITY OF ITS
PRODUCTION CAPABILITIES
* POTENTIAL IMPACT OF PANDEMIC REMAINS VERY UNCERTAIN BASED
ON
CURRENT AVAILABLE INFORMATION
Source text for Eikon: ID:nBw2ygGLCa
Further company coverage: MEMS.PA
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7785110;))